CONSOLIDATED BALANCE SHEETS (EUR €) In Thousands, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2011
Current Assets
Cash	€ 286	€ 382
Receivables other	43	61
Prepaid expenses	52	54
Total current assets	381	497
Property and equipment, net of accumulated depreciation of E261 and E239 at December 31, 2012 and 2011, respectively	28	49
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	9,346	9,483
Current Liabilities
Accounts payable	1,325	1,027
Current portion of convertible notes payable to related Parties	34,723	5,711
Total current liabilities	36,048	6,738
Convertible notes payable to related parties, less current portion	0	25,331
Acquisition-related contingent consideration	6,533	5,753
Total liabilities	42,581	37,822
Shareholders' Equity (Deficit)
Common stock, U.S. $.01 par value; 495,000,000 shares authorized; issued 295,318,813 at December 31, 2012 and 276,017,339 at December 31, 2011	2,468	2,322
Preferred stock, U.S. $.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	33,783	32,732
Deficit accumulated during the development stage	(70,168)	(64,057)
Accumulated other comprehensive income	682	664
Total shareholders' equity (deficit)	(33,235)	(28,339)
Total liabilities and shareholders' equity (deficit)	€ 9,346	€ 9,483